Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer

被引：0
|
作者：
Liu, Bo [1 ]
Drago, Joshua Z. [1 ]
Rao, Yi [1 ]
Pereira, Patricia R. [2 ]
Safonov, Anton [1 ]
Marra, Antonio [1 ]
Ahmed, Mehnaj S. [1 ]
Modi, Shanu [1 ]
Reis-Filho, Jorge S. [1 ]
Montemurro, Filippo [3 ]
Razavi, Pedram [1 ]
Lewis, Jason S. [1 ]
Chandarlapaty, Sarat [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Candiolo Canc Inst, Turin, Italy
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1787
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Antibody-Drug Conjugates in Breast Cancer: Spotlight on HER2
    Abelman, Rachel Occhiogrosso
    Medford, Arielle
    Spring, Laura
    Bardia, Aditya
    CANCER JOURNAL, 2022, 28 (06): : 423 - 428
  • [2] Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2?
    Nicolo, Eleonora
    Repetto, Matteo
    Bielo, Luca Boscolo
    Tarantino, Paolo
    Curigliano, Giuseppe
    CANCER JOURNAL, 2022, 28 (06): : 436 - 445
  • [3] Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer
    Duro-Sanchez, Santiago
    Nadal-Serrano, Mercedes
    Lalinde-Gutierrez, Marta
    Arenas, Enrique Javier
    Morales, Cristina Bernado
    Morancho, Beatriz
    Escorihuela, Marta
    Perez-Ramos, Sandra
    Escriva-de-Romani, Santiago
    Gandullo-Sanchez, Lucia
    Pandiella, Atanasio
    Esteve-Codina, Anna
    Rodilla, Veronica
    Dijcks, Fred A.
    Dokter, Wim H. A.
    Cortes, Javier
    Saura, Cristina
    Arribas, Joaquin
    CANCER RESEARCH, 2022, 82 (24) : 4670 - 4679
  • [4] Recent advances of antibody-drug conjugates in treating breast cancer with different HER2 status
    Qiu, Yue
    Shi, Yaqin
    Chao, Zhujun
    Zhu, Xinyu
    Chen, Yan
    Lu, Linlin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [5] Antibody-drug conjugates in HER2-positive breast cancer
    Li Lixi
    Zhang Di
    Liu Binliang
    Lv Dan
    Zhai Jingtong
    Guan Xiuwen
    Yi Zongbi
    Ma Fei
    中华医学杂志英文版, 2022, 135 (03) : 261 - 267
  • [6] Antibody-drug conjugates in HER2-positive breast cancer
    Li, Lixi
    Zhang, Di
    Liu, Binliang
    Lv, Dan
    Zhai, Jingtong
    Guan, Xiuwen
    Yi, Zongbi
    Ma, Fei
    CHINESE MEDICAL JOURNAL, 2022, 135 (03) : 261 - 267
  • [7] Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges
    Guidi, Lorenzo
    Pellizzari, Gloria
    Tarantino, Paolo
    Valenza, Carmine
    Curigliano, Giuseppe
    CANCERS, 2023, 15 (04)
  • [8] Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer
    Najjar, Mariana K.
    Manore, Sara G.
    Regua, Angelina T.
    Lo, Hui-Wen
    GENES, 2022, 13 (11)
  • [9] New antibody-drug conjugates for HER2-positive breast cancer
    Gourd, Katherine
    LANCET ONCOLOGY, 2020, 21 (01): : 28 - 28
  • [10] HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
    Alberto Ocaña
    Eitan Amir
    Atanasio Pandiella
    Breast Cancer Research, 22
12345